Donald Mager named chair of UB’s Department of Pharmaceutical Sciences

BUFFALO, NY – Donald E. Mager, PharmD, PhD, has been named chair of the Department of Pharmaceutical Sciences at the University at Buffalo.

Mager is an internationally recognized scientist in pharmacokinetics and pharmacodynamics. In his previous work as Vice President of the Department, he was instrumental in developing and maintaining strong relationships across the pharmaceutical industry as well as understanding and appreciating the unique role that the department has played in the development of contemporary pharmaceutical sciences.

As Chair, he will continue to reinforce these important roles and focus on departmental leadership in drug development and other evolving areas of pharmaceutical science.

Mager succeeds Marilyn Morris, PhD, who during her six years as President was responsible for leading many key initiatives, including the creation of a systems pharmacology program, protein engineering and biobased drug delivery, supported by a $1 million investment from State University. of the New York Empire’s Innovation Program and the launch of a new Master of Science program in Pharmacometrics and Personalized Medicine.

“Don joins a long line of truly distinguished professorships to emerge from the faculty. I have deep respect for the history of this department and its unique role in the development of pharmaceutical sciences, and boundless optimism for its continued success under Don’s leadership,” said Gary Pollack, PhD, Dean of UB School of Pharmacy and Pharmaceutical Sciences. . “I would also like to recognize and thank Dr. Marilyn Morris, who has shown exceptional leadership as President over the past six years. She leaves an extremely solid foundation on which Don can build.

Mager joined UB in 2004. His research has led to the creation of new theoretical concepts and applications related to targeted drug delivery, evaluation of monoclonal antibody properties, and development of cancer chemotherapy models. He has received consistent federal and industry funding over the course of his career, has published over 155 articles in peer-reviewed journals, and has been a guest speaker at over 200 national and international meetings and symposia.

Mager is a Fellow and Past President of the International Society of Pharmacometrics (ISoP), and he is a Fellow and current President of the American College of Clinical Pharmacology. He is also a Fellow of the American Academy for the Advancement of Science, the American Association of Pharmaceutical Scientists (AAPS), and the International Pharmaceutical Federation.

He received the AAPS New Investigator Award in 2007, an ISoP Innovation Award, the American Society for Clinical Pharmacology and Therapeutics Malle Jurima-Romet Mid-Career Leadership Award, and a State University of New York Chancellor’s Award for Excellence in Scholarship and Creative Activity , all awarded in 2017.

“I am deeply touched and honored to be named the next Chair of the Department of Pharmaceutical Sciences. I would like to add my appreciation to Dr. Marilyn Morris and past presidents, Drs. William Jusko and Ho-Leung Fung for outstanding management,” Mager said. “Our department has a rich tradition of excellence, and I am delighted to work with all members of our department and our school to maintain this tradition while advancing the discovery and dissemination of new knowledge in the search for innovative therapies. and improved.”

Mager is a graduate faculty member in Experimental Therapeutics at Roswell Park Comprehensive Cancer Center and is President and CEO of Enhanced Pharmacodynamics, LLC.

He received his Bachelor of Pharmacy in 1991, his PharmD in 2000, and his Ph.D. in 2002, all from UB.